Dolby Laboratories Sees Q4 Adj. EPS $0.22-$0.37 vs $0.42 Est., Sales $225M-$255M vs $251.74M Est.; Sees FY20 Adj. EPS $2.76-$2.91 vs $2.36 Est., Sales $1.12B-$1.15B vs $1.13B Est.